Menorrhagia: treatment options.

[1]  A. Lethaby,et al.  Surgery versus medical therapy for heavy menstrual bleeding. , 2016, The Cochrane database of systematic reviews.

[2]  I. Nilsson,et al.  Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. , 2009, Scandinavian journal of haematology.

[3]  J. Semmens,et al.  Morbidity outcomes of 78 577 hysterectomies for benign reasons over 23 years , 2008, BJOG : an international journal of obstetrics and gynaecology.

[4]  M. Makris,et al.  Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  D. Mansour.  Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system. , 2007, Best practice & research. Clinical obstetrics & gynaecology.

[6]  J. Heit,et al.  A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis. , 2007 .

[7]  D. Archer.  Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. , 2006, Contraception.

[8]  G. Dolan,et al.  The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders. , 2005, American journal of obstetrics and gynecology.

[9]  A. Ikomi,et al.  An evaluation of troublesome inter-menstrual bleeding in menorrhagic users of the LNG-IUS , 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[10]  A. Hare,et al.  Pregnancy following endometrial ablation: a review article , 2005, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[11]  D. Economides,et al.  The use of levonorgestrel‐releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders , 2004, BJOG : an international journal of obstetrics and gynaecology.

[12]  P. Kouides,et al.  Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. , 2004, Obstetrics and gynecology.

[13]  D. Economides,et al.  von Willebrand disease in women with menorrhagia: a systematic review , 2004, BJOG : an international journal of obstetrics and gynaecology.

[14]  A. Douglas,et al.  Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. , 2004, American journal of obstetrics and gynecology.

[15]  G. Dolan,et al.  Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  A. Stewart,et al.  Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. , 2004, JAMA.

[17]  A. Di Spiezio Sardo,et al.  Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. , 2003, Human reproduction.

[18]  O. Istre,et al.  Repeat hysteroscopic surgery reduces the hysterectomy rate after endometrial and myoma resection. , 2003, The Journal of the American Association of Gynecologic Laparoscopists.

[19]  J. Astermark,et al.  Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  R. Schwartz,et al.  Platelet functional defects in women with unexplained menorrhagia , 2003, Journal of thrombosis and haemostasis : JTH.

[21]  M. Hickey,et al.  Endometrial destruction techniques for heavy menstrual bleeding: a Cochrane review. , 2002, Human Reproduction.

[22]  D. Economides,et al.  DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo‐controlled crossover study , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  E. Ekholm,et al.  Comparison of ovarian cyst formation in women using the levonorgestrel‐releasing intrauterine system vs. hysterectomy , 2002, Ultrasound in Obstetrics and Gynecology.

[24]  M. Olsen,et al.  Type I von Willebrand's Disease Presenting as Recurrent Corpus Hemorrhagicum , 2002, Obstetrics and gynecology.

[25]  M. Blombäck,et al.  Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[26]  M. Tuppurainen,et al.  Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. , 2002, American journal of obstetrics and gynecology.

[27]  I. Fraser,et al.  Estimating Menstrual Blood Loss in Women With Normal and Excessive Menstrual Fluid Volume , 2001, Obstetrics and gynecology.

[28]  S. Lethagen,et al.  No Increased Risk of Venous Thrombosis in Women Taking Tranexamic Acid , 2001, Thrombosis and Haemostasis.

[29]  J. Vandenbroucke,et al.  Oral Contraceptives, Hormone Replacement Therapy and Thrombosis , 2001, Thrombosis and Haemostasis.

[30]  A. Fisher,et al.  Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. , 2001, JAMA.

[31]  C. Leissinger,et al.  High‐dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  S. Grénman,et al.  Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial , 2001, The Lancet.

[33]  R. Jordan,et al.  The effectiveness of the levonorgestrel‐releasing intrauterine system in menorrhagia: a systematic review , 2001, BJOG : an international journal of obstetrics and gynaecology.

[34]  R. Luoto,et al.  Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland , 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[35]  J. Crane,et al.  Successful intrauterine pregnancy after endometrial ablation. , 2000, The Journal of the American Association of Gynecologic Laparoscopists.

[36]  Abshire,et al.  Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[37]  V. Odlind,et al.  Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. , 1999, Acta obstetricia et gynecologica Scandinavica.

[38]  I. Cameron,et al.  Randomised comparative trial of the intrauterine system and norethisterone levonor gestrel for treatment of idiopathic menorrhagia , 1998 .

[39]  P. Mannucci,et al.  Prospective Multicenter Study on Subcutaneous Concentrated Desmopressin for Home Treatment of Patients with von Willebrand Disease and Mild or Moderate Hemophilia A , 1996, Thrombosis and Haemostasis.

[40]  E. Thomas.  Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids. , 1996, British journal of obstetrics and gynaecology.

[41]  J. Bonnar,et al.  Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid , 1996, BMJ.

[42]  C. Lindoff,et al.  Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161) , 1995, British journal of obstetrics and gynaecology.

[43]  P. Foster,et al.  The Reproductive Health of Women with von Willebrand Disease Unresponsive to DDAVP: Results of an International Survey , 1995, Thrombosis and Haemostasis.

[44]  J. Bonnar,et al.  The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding , 1994, Acta obstetricia et gynecologica Scandinavica.

[45]  E. Thomas,et al.  The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding , 1991, British journal of obstetrics and gynaecology.

[46]  I. Fraser,et al.  Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[47]  J. Bonnar,et al.  Comparison between mefenamic acid and danazol in the treatment of established menorrhagia , 1989, British journal of obstetrics and gynaecology.

[48]  J. Sixma,et al.  DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. , 1984, Blood.

[49]  B. Wiman,et al.  On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. , 1979, Biochimica et biophysica acta.

[50]  P. Mannucci,et al.  Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs , 1975, British journal of haematology.

[51]  Cash Jd,et al.  Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man. , 1974 .

[52]  R. Kadir,et al.  17 Levonorgestrel-releasing intrauterine system for the management of menorrhagia in women with inherited bleeding disorders: Long term follow-up , 2007 .

[53]  A. Lethaby,et al.  Danazol for heavy menstrual bleeding. , 2002, The Cochrane database of systematic reviews.

[54]  K. Andersson.  The levonorgestrel intrauterine system: more than a contraceptive. , 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[55]  A. Lethaby,et al.  Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. , 2000, The Cochrane database of systematic reviews.

[56]  A. PozoAvalos.  World Health Organization (WHO) eligibility criteria for contraceptive use , 1996 .